Impel NeuroPharma Inc. announced the appointment of Jon Congleton as the company's new President and Chief Executive Officer (CEO). Congleton has over 30 years' experience in biopharmaceutical company leadership including pipeline development, commercial strategy and general management. Most recently he was President and CEO of Nivalis Therapeutics where he successfully executed the company's IPO and clinical programs.